GCAT-IGTP and ISGlobal launch third year of COVICAT-CONTENT study

The COVICAT-CONTENT 2023 study begins today, with the aim of monitoring COVID-19 in different cohorts in Catalonia and the rest of Spain. Researchers from the Barcelona Institute for Global Health (ISGlobal) and the GCAT'Genomes for Life project of the Germans Trias i Pujol Research Institute (IGTP) evaluate the genetic and epidemiological determinants associated with the disease, as well as the long-term effects of the pandemic on people's physical and mental health and the evolution of the immune response. In this way, the objective is to help define predictive models and control policies for similar situations in the future.

IGTP will coordinate a European project to improve the diagnosis and treatment of neurofibromatoses

Researchers from the Clinical Genomics Group at Germans Trias i Pujol Research Institute (IGTP) and the Genetics Service at Germans Trias i Pujol Hospital (HUGTiP) will coordinate the project EURONET-NF, which aims to improve genetic diagnosis for patients with neurofibromatoses and schwannomatosis (NF-SWN). The project, which involves 6 countries, has been awarded around €1.6 million in funding by the European Union for the next 3 years.Researchers from the Clinical Genomics Group at Germans Trias i Pujol Research Institute (IGTP) and the Genetics Service at Germans Trias i Pujol Hospital (HUGTiP) will coordinate the project EURONET-NF, which aims to improve genetic diagnosis for patients with neurofibromatoses and schwannomatosis (NF-SWN). The project, which involves 6 countries, has been awarded around €1.6 million in funding by the European Union for the next 3 years.

Two IGTP projects, financed with 1.6 million euros by the European Commission

The European Commission has granted two projects to the IGTP within the HORIZON programme, which add up to a total of 1,670,346 euros in funding and deal with the preclinical development of immunotherapies.

Research impulse into hepatoblastoma, the main childhood liver cancer

A collaborative CIBER project will boost hepatoblastoma (HB) research to identify new therapeutic targets that will allow strategies to be developed to improve the prognosis of those children who currently do not survive the disease. The project coordinated by Carolina Armengol, principal CIBEREHD researcher at the Germans Trias i Pujol Research Institute (IGTP) is a collaboration between 5 CIBER groups belonging to the Hepatic and Digestive Diseases area (CIBEREHD) and the Cancer area (CIBERONC).

The 'Survival vs. Resilience' project will turn Badalona into a laboratory of art and science to anticipate the future of society

The of Fundación Épica of La Fura dels Baus Project, in collaboration with the Institut Germans Trias i Pujol and the Barcelona Institute of Science and Technology will take place from 11-24 July at the old CACI factory in Badalona.

The “Escoles Sentinella” network proves the safety of schools concerning COVID-19 and presents the results of the second year of the project at the project congress

- "Escoles Sentinella" has identified areas and methodologies for improvement that can be incorporated into policies to prevent infections with SARS-CoV-2 and other pathogens in the coming years.

- The "Escoles Sentinella" network monitors SARS-CoV-2 infection and its determinants in the school environment, including CO₂ levels in classrooms, through a participatory research approach by the educational community and incorporating participants' recommendations. 

An ISGlobal Project on Malaria Vivax at the IGTP will Receive Funding from the CaixaResearch Programme

The project, led by Hernando A del Portillo, is one of the 30 projects selected from over 600 proposals presented in the 2021 call. The "CaixaResearch" programme on Health Research has selected 30 new cutting-edge biomedical research projects in Spain and Portugal, including the one led by Hernando A del Portillo, ICREA researcher at the Barcelona Institute for Global Health (ISGlobal) and co-affiliated with the Germans Trias i Pujol Institute (IGTP).

First event for European Performing Science Night completed

A total of 23 researchers have taken part in the first event of the European project European Performing Science Night (EPSN) part of European Researcher's Night a European public event that brings scientists and society together. All three research groups on the camps taking part in the project participated in the workshop.

The IGTP participates in a pioneer EU project to investigate micro and nanoplastics impact and consequences on human health

PLASTICHEAL project will develop new methodologies and will provide reliable scientific evidence for regulators to set the knowledge basis for adequate risk assessment. The results will draw a variety of experimental human models and measuring potential health effects under short and long-term conditions. The researchers at the IGTP will focus on the study of the affect of plastics to the immune response to different microorganisms.

The start of a new international clinical trial to improve treatment for tuberculosis with anti-inflammatory agents

The Experimental Tuberculosis Group at the IGTP has set up this trial, coordinated from Can Ruti, within the European project H2020 ‘SMA-TB’. The study will evaluate the efficacy and safety of adding acetylsalicylic acid or ibuprofen to the antibiotic treatments applied for tuberculosis. It is a phase II trial which will be carried out in South Africa and Georgia, two of the countries the WHO has in its sights to control this infectious disease. The trial has been prepared in the midst of the pandemic, with the added challenge of coordinating it with the restrictions and different stages of the epidemic in each of the countries involved.